Liquid Biopsy Market
Advancement in next-generation sequencing (NGS) for patients with advanced stages of cancer is propelling liquid biopsy market growth. North America emerged as the largest market for the global liquid biopsy market, with a 48.11% share of the market revenue in 2023.
Click to Visit Site